🚨 Important Alert for Users of Ozempic, Wegovy, Rybelsus, or Mounjaro! 🚨
The Medicines & Healthcare products Regulatory Agency (MHRA) has issued an urgent message for anyone taking Ozempic, Wegovy, Rybelsus, or Mounjaro. These medications, known as GLP-1 receptor agonists, help manage conditions like diabetes and support weight loss by mimicking a hormone that makes you feel full. However, there’s a call for vigilance due to potential severe side effects, including acute pancreatitis.
If you or a loved one has experienced a severe reaction while on these meds, you can help make future prescribing safer by reporting it through the Yellow Card scheme. This initiative is part of a study with Genomics England to understand how genetics may impact side effects. Your participation could be crucial to preventing such issues in others by tailoring safer medication plans!
Always remember: these medications are licensed for specific medical conditions and should not be used solely for cosmetic weight loss.
Stay informed and stay safe! 🌟
#HealthAlert #MedicationSafety #Ozempic #Wegovy #Rybelsus #Mounjaro #MHRA